Insider Transactions Reported by 8 Insiders of Turn Therapeutics Inc.

Symbol
TTRX on Nasdaq
Location
Westlake Village, CA

Insiders trading volume in the past year

Turn Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ARTHUR F. GOLDEN Director $208,470 +$92,873 +80% 24 Nov 2025
Martin William Dewhurst Director $86,217 07 Jan 2026
Zuraiz Chaudhary Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. $43,750 +$21,090 +93% 12 Dec 2025
Neilesh Shailesh Ghodadra Chief Medical Officer, Director 08 Oct 2025
Andrew Gengos Director 08 Oct 2025
Bradley Evan Burnam Chief Executive Officer, Director, 10%+ Owner 07 Oct 2025
Kent Edward Kester Director 08 Oct 2025
Abraham Chesed Board Observer 23 Oct 2025

Recent Insider Transactions by Companies or Individuals for Turn Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.